NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹277 Cr | ₹257 Cr | ₹217 Cr | ₹198 Cr | ₹149 Cr |
What is the latest Profit & Loss Account Balance ratio of NGL FINECHEM ?
Year | Profit & Loss Account Balance |
---|---|
Mar2025 | ₹277 Cr |
Mar2024 | ₹257 Cr |
Mar2023 | ₹217 Cr |
Mar2022 | ₹198 Cr |
Mar2021 | ₹149 Cr |
How is Profit & Loss Account Balance of NGL FINECHEM Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2025 | ₹277 Cr | 7.70 | |
Mar2024 | ₹257 Cr | 18.45 | |
Mar2023 | ₹217 Cr | 9.77 | |
Mar2022 | ₹198 Cr | 32.69 | |
Mar2021 | ₹149 Cr | - |
Compare Profit & Loss Account Balance of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹884.4 Cr | -0.4% | 15.7% | -33.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,718.0 Cr | 1% | -0.2% | -13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,282.0 Cr | -2.7% | -2.2% | 17.6% | Stock Analytics | |
CIPLA | ₹125,351.0 Cr | -1.7% | 4.1% | -5.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,267.0 Cr | 1% | 1.3% | 4.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,952.0 Cr | 2.5% | 7.7% | -6.7% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -0.4% |
15.7% |
-33.2% |
SENSEX | 1.2% |
0.7% |
-1.5% |
You may also like the below Video Courses